Ranitidine study finds no elevated risk of cancer… despite finding elevated cancer rates

by

Research led by Seng Chan You, MD, at the Yonsei University College of Medicine, Korea, has investigated the risk of cancer associated with use of the drug ranitidine compared to other histamine-2 receptor antagonists (H2RAs) using a large-scale cohort study across multiple countries.

Leave A Comment

Your email address will not be published. Required fields are marked *